Hos patienter med plaque psoriasis, som blev behandlet med Enbrel, var der ved første besøg (2 uger) signifikant respons sammenlignet med placebo. Dette blev opretholdt gennem 24 ugers behandling.
Among patients with plaque psoriasis who received Enbrel, significant responses relative to placebo were apparent at the time of the first visit (2 weeks) and were maintained through 24 weeks of therapy.